Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus with Chemotherapy for Clear Cell Ovarian Cancer
NCT01196429Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2010
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of temsirolimus in ovarian clear cell carcinoma (OCCC), sponsored by National Cancer Institute. Started Aug 2010; status: completed.
02
Drugs
temsirolimus
03
Conditions
ovarian clear cell carcinoma (OCCC)
Beyond the preview
Go deeper on NCT01196429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196429.